Sofregen Medical Acquires SERI® Surgical Scaffold Product Line from Allergan

Company Expands Silk-Based Medical Technology Platform for Soft Tissue Repair

Cambridge, Mass. — November 11, 2016 — Sofregen Medical Inc., an innovative company committed to advancing silk-based medical technologies to address soft tissue defects, today announced the acquisition of SERI® Surgical Scaffold product line from Allergan plc. Polaris Partners and other founding investors provided financing...

Read more →


img_team_investor_polaris_square.jpg

Sofregen Medical Raises $6.2 Million in Series A Funding from Polaris Partners and Other Founding Investors

MEDFORD, Mass.–(BUSINESS WIRE)–Sofregen Medical Inc. (Sofregen), the company pioneering silk-based medical technologies to address soft tissue defects, today announced a $6.2 million Series A financing from Polaris Partners and other founding investors who previously seeded the company. Founded in 2014 to advance technology developed at Tufts University and the University of Pittsburgh, Sofregen has a...

Read more →